FIELD: medicine.
SUBSTANCE: invention refers to molecular oncology and may be used for differential diagnosis of gastric cancer of different histological types. The method comprises obtaining of DNA from the biopsy; amplification of GSTP1, NFKB1 HV2 loci fragments using polymerase chain reaction in real time (RT-PCR) by means of a set of highly specific primers; quantitative interpretation of amplification results. Implementation of the method is possible with operating material and tissue biopsies obtained during gastroscopy; the results shall be recorded once at the end of the study, the method takes less than 10 hours.
EFFECT: method allows efficient and timely identification of G3 adenocarcinoma and castration-cell stomach cancer, which enables more accurate preoperative prediction and promotes adoption of correct tactics of treatment and improvement of its results.
2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
TEST SYSTEM “HV2 mtDNA-PCR” FOR PREDICTING THE DEVELOPMENT OF METASTASES IN PATIENTS WITH GASTRIC CANCER | 2017 |
|
RU2683571C1 |
METHOD FOR PREDICTION OF METASTASES DEVELOPMENT IN PATIENTS WITH GASTRIC CANCER | 2016 |
|
RU2624505C1 |
METHOD FOR PREDICTING THE DEVELOPMENT OF METASTASES IN REGIONAL LYMPH NODES IN PATIENTS WITH GASTRIC ADENOCARCINOMA | 2017 |
|
RU2661600C1 |
MINIMALLY INVASIVE METHOD FOR DETECTING SENSITIVITY OF RECTAL TUMOUR TO RADIATION THERAPY BASED ON CHANGE IN ABUNDANCE OF N2AX AND RBBP8 GENES | 2019 |
|
RU2740576C1 |
MINIMALLY INVASIVE METHOD FOR DIAGNOSTICS OF LUNG CANCER ON BASIS OF CHANGING COPY NUMBER OF MTDNA HV2 LOCUS | 2018 |
|
RU2678227C1 |
METHOD FOR DIAGNOSING METASTASES OF COLON CANCER | 2016 |
|
RU2647470C2 |
METHOD OF PREDICTING METASTASIS OF STOMACH CANCER TUMORS | 2021 |
|
RU2806432C2 |
MINIMALLY INVASIVE METHOD FOR DIAGNOSING METASTATIC LESIONS OF REGIONAL LYMPH NODES IN PATIENTS WITH CERVICAL CANCER BASED ON THE COPY NUMBER OF THE CCND1 AND PPARGC1A GENES | 2021 |
|
RU2766774C1 |
ESSC-TIPE-1TEST-SYSTEM FOR MOLECULAR-GENETIC TYPING OF SQUAMOUS OESOPHAGEAL CANCER | 2020 |
|
RU2742468C1 |
METHOD FOR PREDICTION OF ENDOMETRIAL CANCER PATIENTS SURVIVAL ON THE BASIS OF THE ESR1 GENE EXPRESSION LEVEL | 2015 |
|
RU2611352C1 |
Authors
Dates
2017-03-15—Published
2015-10-12—Filed